Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241525 · ClinicalTrials.gov registry record
CT for Pulmonary Thromboembolic Disease
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02241525: Clinical Trial study, sponsored by University of Maryland, Baltimore.
NCT02241525 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02241525 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography (CTPA) for the diagnosis of pulmonary thromboembolic disease.
Primary Outcome
The primary endpoint is to study the feasibility( bi-phasic vs. singular pahse contrast injection (by comparison analysis)) of individually optimized bi-phasic contrast injection for CTPA scan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-05 |
Why NCT02241525 stopped before completion
NCT02241525 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02241525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02241525 about?
NCT02241525 is a clinical study titled "CT for Pulmonary Thromboembolic Disease". Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography (CTPA) for the diagnosis of pulmonary thromboembolic disease.
What is the current status of trial NCT02241525?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-02. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT02241525?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia